Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine template: Organic and medicinal chemistry approach

Current Organic Chemistry

Volumn 10, Issue 3, 2006, Pages 259-275

  Baraldi, Pier Giovanni ^a   Tabrizi, Mojgan Aghazadeh ^a   Romagnoli, Romeo ^a   El Kashef, Hussein ^b   Preti, Delia ^a   Bovero, Andrea ^a   Fruttarolo, Francesca ^a   Gordaliza, Marina ^c   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Assiut University   (Egypt)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

5 N ethylcarboxamidoadenosine; Adenosine receptor subtypes; Ethylchloroformate; Hexamethyldisilazane; Pyrazole nitrogen; Pyrazolotriazolo pyrimidines

Indexed keywords

2 (2 FURYL) 7H PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDIN 5 AMINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 2 (2 FURYL) 7 (3 PHENYLPROPYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 7H PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE DERIVATIVE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; AZEPINE DERIVATIVE; LIGAND; NITROGEN; PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALKYLATION; CHEMICAL MODIFICATION; CHEMISTRY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEPARATION TECHNIQUE; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

EID: 33646007701     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527206775473869     Document Type: Review

References (42)

1. Fredholm, B.B.; Abbracchio, M.P.; Burnstok, G.; Daly, J.W.; Harden, T.K.; Jacobson, K.A.; Leff, P.; Williams, M. Pharmacol. Rev. 1994, 46, 143.
2. Kostopoulos, G.K. In Neurotransmitters and cortical function: from molecules to mind. Avoli Ed., Plenum Press, New York, 1988, pp. 415.
3. Burnstok, G.A. In Cell membrane receptors for drugs and hormones. Bolis, L.; Straub, R.W. Ed., Raven Press, New York, 1978, pp. 107-118.
4. Fredholm, B.B.; Arslan, G.; Halldner, L.; Kull, B.; Schulte, G.; Wasserman, W. Naunyn- Schmied Arch. Pharmacol. 2000, 362, 364.
5. Ralevic, V.; Burnstok, G. Pharmacol. Rev. 1998, 50, 413.
6. Strohmeir, G.R.; Reppert, S.M.; Lencer, W.I; Madaa, J.L. J. Biol. Chem. 1995, 270, 2387.
7. Ferrè, S.; Fredholm, B.B.; Morelli, M.; Popoli, P.; Fuxe, K. Trends Neurosci. 1997, 20, 482.
8. Ferrè, S.; Fuxe, K.; Von Euler, G.; Johansson, J.; Fredholm, B.B. Neuroscience, 1992, 51, 501.
9. Ramkumar, V.; Stiles, G.L.; Beaven, M.A.; Ali, H. J. Biol. Chem. 1993, 268, 16887.
10. Brambilla, R.; Cattabeni, F.; Ceruti, S.; Barbieri, D.; Franceschi, C.; Kim, Y.; Jacobson, K.A.; Klotz, K.N.; Iohse, M.J.; Abbracchio, M.P. Naunyn-Schmied. Arch. Pharmacol. 2000, 361, 225.
11. Ongini, E.; Fredholm, B.B. Trends Pharmacol. Sci. 1996, 17, 364.
12. Varani, K.; Gessi, S.; Dionisotti, S.; Ongini, E.; Borea, P.A. Br, J. Pharmacol. 1998, 123, 1723.
13. Gessi, S.; Varani, K.; Merighi, S.; Ongini, E.; Borea, P.A. Br. J. Pharmacol. 2000, 129, 2.
14. Jacobson, K.A.; Moro, S.; Kim, Y.C.; Li, A.H. Drug Dev. Res. 1998, 45, 113.
15. Beaven, M.A.; Ramkumar, V.; Ali, H. Trends Pharmacol. Sci. 1994, 15, 13.
16. Baraldi, P.G.; Cacciari, B.; Spalluto, G.P.; Bergonzoni, E.; Dionisotti, S.; Ongini, E.; Varani, K.; Borea, P.A. J. Med. Chem. 1998, 41, 2126.
17. Baraldi, P.G.; Cacciari, B.; Dionisotti, S.; Egan, J.; Spalluto, G.P.; Zocchi, C. J. Labeled Compds. Radiopharm. 1996, 38, 725.
18. Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Klotz, K.N.; Leung, E.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P.A. J. Med. Chem. 1999, 42, 4473.
19. Baraldi, P.G.; Borea, P.A. Trends Pharmacol. Sci. 2000, 21, 456.
20. Varani, K.; Merighi, S.; Gessi, S.; Klotz, K.N.; Leung, E.; Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Spalluto, G.P.; Bores, P.A. Mol. Pharmacol. 2000, 57, 968.
21. Francis, J.E.; Cash, W.; Psychoyos, S.; Ghai, G.; Wenk, P.; Friedman, R.C.; Atkins, C.; Warren, V.; Furness, P.; Hyun, J.L. J. Med. Chem. 1988, 31, 1014.
22. Baraldi, P.G.; Cacciari, B.; Spalluto, G.P.; Pineda de las Infantas, M.J.; Zocchi, C.; Ferrara, S.; Dionisotti, S. Farmaco, 1996, 51, 297.
23. Gatta, F.; Del Giudice, M.R.; Borioni, A.; Borea, P.A.; Dionisotti, S.; Ongini, E. Eur. J. Med. Chem. 1993, 28, 569.
24. Zocchi, C.; Ongini, E.; Conti, A.; Monopoli, A.; Negretti, A.; Baraldi, P.G.; Dionisotti, S. J. Pharmacol. Exp. Ther. 1996, 276, 398.
25. Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Spalluto, G.P.; Monopoli, A.; Ongini, E.; Varani, K.; Borea, P.A. J. Med. Chem. 2002, 45, 115.
26. Baraldi, P.G.; Bovero, A.; Fruttarolo, F.; Romagnoli, R.; Tabrizi, M.A.; Preti, D.; Varani, K.; Borea, P.A.; Moorman, A.R. Bioorg. Med. Chem. 2003, 11, 4161.
27. Baraldi, P.G.; Cacciari, B.; Pineda de Las Infantas, M.J.; Romagnoli, R.; Spalluto, G.P.; Volpini, R.; Costanzi, S.; Vittori, S.; Cristalli, G.; Melman, N.; Park, S.; Ji, X.D.; Jacobson, K.A. J. Med. Chem. 1998, 41, 3174.
28. Schering Corporation, NJ 07033-0530 (US), International Publication Number: WO01/92264 A1, 2001.
29. Seela, F.; Steker, H. Helv. Chim. Acta, 1986, 69, 1602.
30. Baraldi, P.G.; Cacciari, B.; Moro, S.; Spalluto, G.P.; Pastorin, G.; Da Ros, T.; Klotz, K.N.; Varani, S.; Gessi, S.; Borea, P.A. J. Med Chem. 2002, 45, 770.
31. Maconi, A.; Pastorin, G.; Da Ros, T.; Spalluto, G.P.; Gao, Z.; Jacobson, K.A.; Baraldi, P.G.; Cacciari, B.; Varani, K.; Moro, S.; Borea, P.A. J. Med. Chem. 2002, 45, 3579.
32. Curtius, T.; Mohr, E. Ber. 1898, 31, 2493.
33. Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Varani, K.; Merighi, S.; Gessi, S.; Borea, P.A.; Leung, E.; Hockey, S.L.; Spalluto, G.P. Bioorg. Med. Chem. Lett. 2000, 10, 209.
34. Baraldi, P.G.; Cacciari, B.; Moro, S.; Romagnoli, R.; Ji, X.; Jacobson, K.A.; Gessi, S.; Borea, P.A.; Spalluto, G.P. J. Med. Chem. 2001, 44, 2735.
35. Bardos, T.J.; Datta-Gupta, N.; Hebborn, P.; Triggle, D.J. J. Chem. Soc. 1965, 8, 167.
36. Baraldi, P.G.; Fruttarolo, F.; Tabrizi, M.A.; Preti D.; Romagnoli, R.; El-Kashef, H.; Moorman, A.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P.A. J. Med. Chem. 2003, 46, 1229.
37. Tominaga, Y.; Honkawa, Y.; Hara, M.; Hosomi, A. J. Het. Chem. 1990, 27, 775.
38. Baraldi, P.G.; Tabrizi, M.A.; Fruttarolo, F.; Bovero, A.; Avitabile, B.; Preti, D.; Romagnoli, R.; Merighi, S.; Gessi, S.; Varani, K.; Borea, P.A. Drug Dev. Res. 2003, 58, 315.
39. Baraldi, P.G.; Tabrizi, M.A.; Bovero, A.; Avitabile, B.; Preti, D.; Fruttarolo, F.; Romagnoli, R.; Varani, .; Borea, P.A. Eur. J. Med. Chem. 2003, 38, 367.
40. Baraldi, P.G.; Cacciari, B.; Borea, P.A.; Varani, K.; Pastorin, G.; Da Ros, T.; Tabrizi, M.A.; Fruttarolo, F.; Spalluto, G.P. Curr. Pharm. Design 2002, 8, 2299.
41. Baraldi, P.G.; El-Kashef, H.; Farghaly, A.R.; Vanelle, P.; Fruttarolo, F. Tetrahedron 2004, 60, 5093.
42. Hozien, Z.A.; Abdel-Wahab, A.A; Hassan, K.M.; Atta, F.M.; Ahmed, S.A. Pharmazie 1997, 52, 753.